Forest's $65M Settlement Over Antidepressants OK'd
A judge has given preliminary approval to a $65 million settlement that allows Forest Laboratories to end a securities class action that claimed it provided misleading information about the safety of...To view the full article, register now.
Already a subscriber? Click here to view full article